Evidence map›Paper›PMID 31308468›Full record

ArticleSpinal cord2019

Carboxy terminal collagen crosslinks as a prognostic risk factor for fall-related fractures in individuals with established spinal cord injury.

Vivien Jørgensen, Hanne Bjørg Slettahjell, Kirsti Skavberg Roaldsen, Emil Kostovski

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Spinal cord, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Vivien JørgensenDepartment of Research, Sunnaas Rehabilitation Hospital, University of Oslo, Oslo, Norway.
Hanne Bjørg SlettahjellDepartment of Research, Sunnaas Rehabilitation Hospital, University of Oslo, Oslo, Norway. hannebjorg.slettahjell@sunnaaas.no.
Kirsti Skavberg RoaldsenDepartment of Research, Sunnaas Rehabilitation Hospital, University of Oslo, Oslo, Norway.
Emil KostovskiDepartment of Research, Sunnaas Rehabilitation Hospital, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0002-7037-1363
University of Oslo · NOOsloMet – Oslo Metropolitan University · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STUDY

designProspective cohort study.

objectiveTo study associations between specific bone turnover markers and fall-related fractures in individuals with spinal cord injury (SCI).

settingRehabilitation Hospital.

methodsCarboxy terminal collagen crosslinks (CTX), type-1 procollagen N-terminal (P1NP), albumin-corrected calcium (Ca

resultsIn total, 29 out of 106 reported having experienced a fall-related fracture post-injury at baseline, and 5 out of 100 had experienced a fall-related bone fracture during the 1 year follow-up. Our main findings were that high levels of serum CTX increased the odds of being in the fracture group, and that 25-hydroxy vitamin D (25 OHD) levels, Ca

conclusionsWe here present an association between high-CTX plasma levels at baseline and fall-related fractures reported during a 1-year follow-up among individuals with established SCI. We recommend studies with larger SCI populations before further clinical implications can be drawn.

Indexed as

Accidental FallsAdultAgedAged, 80 and overBiomarkersBone RemodelingCollagen Type IFemaleFractures, BoneHumansMaleMiddle AgedPrognosisProspective StudiesRisk FactorsSpinal Cord InjuriesBiomarkersCollagen Type I

Identifiers

PMID31308468
PMCPMC6892418
OpenAlexW2960945232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.